- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2020 growth of Sufentanil (API) will have significant change from previous year. By the most conservative estimates of global Sufentanil (API) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Sufentanil (API) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Sufentanil (API) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Purity 98%
Purity 99%
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Injection
Capsule
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Kern Pharma
Cambrex
Hameln Rds
Cristalia
Janssen Pharmaceuticals
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sufentanil (API) Consumption 2016-2026
2.1.2 Sufentanil (API) Consumption CAGR by Region
2.2 Sufentanil (API) Segment by Type
2.2.1 Purity 98%
2.2.2 Purity 99%
2.3 Sufentanil (API) Sales by Type
2.3.1 Global Sufentanil (API) Sales Market Share by Type (2016-2021)
2.3.2 Global Sufentanil (API) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Sufentanil (API) Sale Price by Type (2016-2021)
2.4 Sufentanil (API) Segment by Application
2.4.1 Injection
2.4.2 Capsule
2.5 Sufentanil (API) Sales by Application
2.5.1 Global Sufentanil (API) Sale Market Share by Application (2016-2021)
2.5.2 Global Sufentanil (API) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Sufentanil (API) Sale Price by Application (2016-2021)
3 Global Sufentanil (API) by Company
3.1 Global Sufentanil (API) Sales Market Share by Company
3.1.1 Global Sufentanil (API) Sales by Company (2019-2021)
3.1.2 Global Sufentanil (API) Sales Market Share by Company (2019-2021)
3.2 Global Sufentanil (API) Revenue Market Share by Company
3.2.1 Global Sufentanil (API) Revenue by Company (2019-2021)
3.2.2 Global Sufentanil (API) Revenue Market Share by Company (2019-2021)
3.3 Global Sufentanil (API) Sale Price by Company
3.4 Global Manufacturers Sufentanil (API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sufentanil (API) Product Location Distribution
3.4.2 Players Sufentanil (API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Sufentanil (API) by Region
4.1 Global Sufentanil (API) by Region
4.1.1 Global Sufentanil (API) Sales by Region
4.1.2 Global Sufentanil (API) Revenue by Region
4.2 Americas Sufentanil (API) Sales Growth
4.3 APAC Sufentanil (API) Sales Growth
4.4 Europe Sufentanil (API) Sales Growth
4.5 Middle East & Africa Sufentanil (API) Sales Growth
5 Americas
5.1 Americas Sufentanil (API) Sales by Country
5.1.1 Americas Sufentanil (API) Sales by Country (2016-2021)
5.1.2 Americas Sufentanil (API) Revenue by Country (2016-2021)
5.2 Americas Sufentanil (API) Sales by Type
5.3 Americas Sufentanil (API) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sufentanil (API) Sales by Region
6.1.1 APAC Sufentanil (API) Sales by Region (2016-2021)
6.1.2 APAC Sufentanil (API) Revenue by Region (2016-2021)
6.2 APAC Sufentanil (API) Sales by Type
6.3 APAC Sufentanil (API) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Sufentanil (API) by Country
7.1.1 Europe Sufentanil (API) Sales by Country (2016-2021)
7.1.2 Europe Sufentanil (API) Revenue by Country (2016-2021)
7.2 Europe Sufentanil (API) Sales by Type
7.3 Europe Sufentanil (API) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sufentanil (API) by Country
8.1.1 Middle East & Africa Sufentanil (API) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Sufentanil (API) Revenue by Country (2016-2021)
8.2 Middle East & Africa Sufentanil (API) Sales by Type
8.3 Middle East & Africa Sufentanil (API) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Sufentanil (API) Distributors
10.3 Sufentanil (API) Customer
11 Global Sufentanil (API) Market Forecast
11.1 Global Sufentanil (API) Forecast by Region
11.1.1 Global Sufentanil (API) Forecast by Regions (2021-2026)
11.2.2 Global Sufentanil (API) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Sufentanil (API) Forecast by Type
11.7 Global Sufentanil (API) Forecast by Application
12 Key Players Analysis
12.1 Kern Pharma
12.1.1 Kern Pharma Kern Pharma Company Information
12.1.2 Kern Pharma Sufentanil (API) Product Offered
12.1.3 Kern Pharma Sufentanil (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Kern Pharma Main Business Overview
12.1.5 Kern Pharma Latest Developments
12.2 Cambrex
12.2.1 Cambrex Company Information
12.2.2 Cambrex Sufentanil (API) Product Offered
12.2.3 Cambrex Sufentanil (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Cambrex Main Business Overview
12.2.5 Cambrex Latest Developments
12.3 Hameln Rds
12.3.1 Hameln Rds Company Information
12.3.2 Hameln Rds Sufentanil (API) Product Offered
12.3.3 Hameln Rds Sufentanil (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Hameln Rds Main Business Overview
12.3.5 Hameln Rds Latest Developments
12.4 Cristalia
12.4.1 Cristalia Company Information
12.4.2 Cristalia Sufentanil (API) Product Offered
12.4.3 Cristalia Sufentanil (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Cristalia Main Business Overview
12.4.5 Cristalia Latest Developments
12.5 Janssen Pharmaceuticals
12.5.1 Janssen Pharmaceuticals Company Information
12.5.2 Janssen Pharmaceuticals Sufentanil (API) Product Offered
12.5.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Janssen Pharmaceuticals Main Business Overview
12.5.5 Janssen Pharmaceuticals Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Sufentanil (API) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Purity 98%
Table 3. Major Players of Purity 99%
Table 4. Global Sufentanil (API) Sales by Type (2016-2021) & (K Units)
Table 5. Global Sufentanil (API) Sales Market Share by Type (2016-2021)
Table 6. Global Sufentanil (API) Revenue by Type (2016-2021) & ($ million)
Table 7. Global Sufentanil (API) Revenue Market Share by Type (2016-2021)
Table 8. Global Sufentanil (API) Sale Price by Type (2016-2021)
Table 9. Global Sufentanil (API) Sales by Application (2016-2021) & (K Units)
Table 10. Global Sufentanil (API) Sales Market Share by Application (2016-2021)
Table 11. Global Sufentanil (API) Value by Application (2016-2021)
Table 12. Global Sufentanil (API) Revenue Market Share by Application (2016-2021)
Table 13. Global Sufentanil (API) Sale Price by Application (2016-2021)
Table 14. Global Sufentanil (API) Sales by Company (2019-2021) & (K Units)
Table 15. Global Sufentanil (API) Sales Market Share by Company (2019-2021)
Table 16. Global Sufentanil (API) Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Sufentanil (API) Revenue Market Share by Company (2019-2021)
Table 18. Global Sufentanil (API) Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Sufentanil (API) Producing Area Distribution and Sales Area
Table 20. Players Sufentanil (API) Products Offered
Table 21. Sufentanil (API) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Sufentanil (API) Sales by Region (2016-2021) (K Units)
Table 25. Global Sufentanil (API) Sales Market Share by Region (2016-2021)
Table 26. Global Sufentanil (API) Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Sufentanil (API) Revenue Market Share by Region (2016-2021)
Table 28. Americas Sufentanil (API) Sales by Country (2016-2021) & (K Units)
Table 29. Americas Sufentanil (API) Sales Market Share by Country (2016-2021)
Table 30. Americas Sufentanil (API) Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Sufentanil (API) Revenue Market Share by Country (2016-2021)
Table 32. Americas Sufentanil (API) Sales by Type (2016-2021) & (K Units)
Table 33. Americas Sufentanil (API) Sales Market Share by Type (2016-2021)
Table 34. Americas Sufentanil (API) Sales by Application (2016-2021) & (K Units)
Table 35. Americas Sufentanil (API) Sales Market Share by Application (2016-2021)
Table 36. APAC Sufentanil (API) Sales by Region (2016-2021) & (K Units)
Table 37. APAC Sufentanil (API) Sales Market Share by Region (2016-2021)
Table 38. APAC Sufentanil (API) Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Sufentanil (API) Revenue Market Share by Region (2016-2021)
Table 40. APAC Sufentanil (API) Sales by Type (2016-2021) & (K Units)
Table 41. APAC Sufentanil (API) Sales Market Share by Type (2016-2021)
Table 42. APAC Sufentanil (API) Sales by Application (2016-2021) & (K Units)
Table 43. APAC Sufentanil (API) Sales Market Share by Application (2016-2021)
Table 44. Europe Sufentanil (API) Sales by Country (2016-2021) & (K Units)
Table 45. Europe Sufentanil (API) Sales Market Share by Country (2016-2021)
Table 46. Europe Sufentanil (API) Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Sufentanil (API) Revenue Market Share by Country (2016-2021)
Table 48. Europe Sufentanil (API) Sales by Type (2016-2021) & (K Units)
Table 49. Europe Sufentanil (API) Sales Market Share by Type (2016-2021)
Table 50. Europe Sufentanil (API) Sales by Application (2016-2021) & (K Units)
Table 51. Europe Sufentanil (API) Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Sufentanil (API) Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Sufentanil (API) Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Sufentanil (API) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Sufentanil (API) Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Sufentanil (API) Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Sufentanil (API) Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Sufentanil (API) Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Sufentanil (API) Sales Market Share by Application (2016-2021)
Table 60. Global Sufentanil (API) Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Sufentanil (API) Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Sufentanil (API) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Sufentanil (API) Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Sufentanil (API) Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Sufentanil (API) Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Sufentanil (API) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Sufentanil (API) Revenue Market Share Forecast by Application (2021-2026)
Table 68. Kern Pharma Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 69. Kern Pharma Sufentanil (API) Product Offered
Table 70. Kern Pharma Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 71. Kern Pharma Main Business
Table 72. Kern Pharma Latest Developments
Table 73. Cambrex Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 74. Cambrex Sufentanil (API) Product Offered
Table 75. Cambrex Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 76. Cambrex Main Business
Table 77. Cambrex Latest Developments
Table 78. Hameln Rds Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 79. Hameln Rds Sufentanil (API) Product Offered
Table 80. Hameln Rds Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 81. Hameln Rds Main Business
Table 82. Hameln Rds Latest Developments
Table 83. Cristalia Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 84. Cristalia Sufentanil (API) Product Offered
Table 85. Cristalia Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 86. Cristalia Main Business
Table 87. Cristalia Latest Developments
Table 88. Janssen Pharmaceuticals Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 89. Janssen Pharmaceuticals Sufentanil (API) Product Offered
Table 90. Janssen Pharmaceuticals Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. Janssen Pharmaceuticals Main Business
Table 92. Janssen Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Sufentanil (API)
Figure 2. Sufentanil (API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sufentanil (API) Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Sufentanil (API) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Sufentanil (API) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Purity 98%
Figure 10. Product Picture of Purity 99%
Figure 11. Global Sufentanil (API) Sales Market Share by Type in 2020
Figure 12. Global Sufentanil (API) Revenue Market Share by Type (2016-2021)
Figure 13. Sufentanil (API) Consumed in Injection
Figure 14. Global Sufentanil (API) Market: Injection (2016-2021) & (K Units)
Figure 15. Sufentanil (API) Consumed in Capsule
Figure 16. Global Sufentanil (API) Market: Capsule (2016-2021) & (K Units)
Figure 17. Global Sufentanil (API) Sales Market Share by Application (2016-2021)
Figure 18. Global Sufentanil (API) Revenue Market Share by Application in 2020
Figure 19. Global Sufentanil (API) Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Sufentanil (API) Revenue Market Share by Company in 2020
Figure 21. Global Sufentanil (API) Sales Market Share by Regions (2016-2021)
Figure 22. Global Sufentanil (API) Revenue Market Share by Region in 2020
Figure 23. Americas Sufentanil (API) Sales 2016-2021 (K Units)
Figure 24. Americas Sufentanil (API) Revenue 2016-2021 ($ Millions)
Figure 25. APAC Sufentanil (API) Sales 2016-2021 (K Units)
Figure 26. APAC Sufentanil (API) Revenue 2016-2021 ($ Millions)
Figure 27. Europe Sufentanil (API) Sales 2016-2021 (K Units)
Figure 28. Europe Sufentanil (API) Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Sufentanil (API) Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa Sufentanil (API) Revenue 2016-2021 ($ Millions)
Figure 31. Americas Sufentanil (API) Sales Market Share by Country in 2020
Figure 32. Americas Sufentanil (API) Revenue Market Share by Country in 2020
Figure 33. Americas Sufentanil (API) Sales Market Share by Type in 2020
Figure 34. Americas Sufentanil (API) Sales Market Share by Application in 2020
Figure 35. United States Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Sufentanil (API) Sales Market Share by Region in 2020
Figure 40. APAC Sufentanil (API) Revenue Market Share by Regions in 2020
Figure 41. APAC Sufentanil (API) Sales Market Share by Type in 2020
Figure 42. APAC Sufentanil (API) Sales Market Share by Application in 2020
Figure 43. China Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Sufentanil (API) Sales Market Share by Country in 2020
Figure 50. Europe Sufentanil (API) Revenue Market Share by Country in 2020
Figure 51. Europe Sufentanil (API) Sales Market Share by Type in 2020
Figure 52. Europe Sufentanil (API) Sales Market Share by Application in 2020
Figure 53. Germany Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Sufentanil (API) Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Sufentanil (API) Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Sufentanil (API) Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Sufentanil (API) Sales Market Share by Application in 2020
Figure 62. Egypt Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Sufentanil (API) Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
